Table 1. Beneficial effects of HDAC inhibition or suppression in polyQ disease models.
HDACi/ treatment | PolyQ model | Effect | Refs. |
---|---|---|---|
SAHA |
HD R6/2 mice |
Improvement of motor skills Reduction of HTT aggregates Restoration of BDNF levels |
57
,
58
|
SAHA |
Human HTT in yeast |
Inhibition of neurotoxic metabolites |
59
|
NaBu |
SCA3 mice |
Restoration of histone acetylation level Improvement of neurological symptoms |
60
|
NaBu |
HD R6/2 mice |
Improvement of neurological symptoms |
22
|
4b |
HD R6/2 mice |
Improvement of motor, body-weight and brain symptoms |
61
|
4b-related compounds |
HD R6/2 mice |
Neuroprotection |
62
|
Sir2 / Rpd3 reduction |
HD flies |
Neuroprotection |
63
|
Sirt1 increase | HD mice | Improvement of motor skills and decreased neurodegeneration |
64 |